Diagnosis and Management of Biliary Tract Cancer

Biliary tract cancer (BTC) are highly aggressive and fatal malignancies. As one of the leading cause death in Republic Korea, BTC amoung various malignancies has been major public health concerns country. Although BTCs, including intrahepatic, perihilar, distal cholangiocarcinoma, relatively low-incidence compared to other cancer, but they represent a problem endemic areas like Korea Asia contries; moreover, incidence intrahepatic cholangiocarcinoma is rising globally. Surgery only curative treatment. The optimal surgical approach depends on anatomical site primary tumour, best outcomes achieved through management by specialist multidisciplinary team. Unfortunately, most patients present with locally advanced or metastatic disease. Only up 20% diagnosed early-stage, suitable for surgery. Despite surgery performed potentially-curative intent, recurrence rates high, around 60-70% expected have disease recurrence. In this review, we an update causes, diagnosis, treatment focus chemotherapy BTC.